Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Journal of Medicinal Chemistry
|
February 3, 2006
SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase
Jay P Powers, Derek E Piper, Yang Li, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 4, 2015
Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4
Zhulun Wang, Daqing Sun, Sheree Johnstone, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2009
Imidazo-pyrazine derivatives as potent CXCR3 antagonists
Xiaohui Du, Darin J Gustin, Xiaoqi Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 26, 2009
Identification of a PPARdelta agonist with partial agonistic activity on PPARgamma
Richard V Connors, Zhulun Wang, Martin Harrison, et al.
Bioorganic & Medicinal Chemistry
|
September 16, 2008
Distinctive molecular inhibition mechanisms for selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1
Hua Tu, Jay P Powers, Jinsong Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 20, 2014
Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4
Yingcai Wang, Richard Connors, Pingchen Fan, et al.
Journal of Molecular Biology
|
May 20, 2009
INT131: a selective modulator of PPAR gamma
Alykhan Motani, Zhulun Wang, Jennifer Weiszmann, et al.
Journal of Medicinal Chemistry
|
March 31, 2012
Structure-guided design, synthesis, and evaluation of guanine-derived inhibitors of the eIF4E mRNA-cap interaction
Xiaoqi Chen, David J Kopecky, Jeff Mihalic, et al.
The Journal of Biological Chemistry
|
May 26, 2018
Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2
Athena Sudom, Santosh Talreja, Jean Danao, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2009
Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)
Daqing Sun, Zhulun Wang, Mario Cardozo, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Journal of Medicinal Chemistry
|
February 3, 2006
SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase
Jay P Powers, Derek E Piper, Yang Li, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 4, 2015
Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4
Zhulun Wang, Daqing Sun, Sheree Johnstone, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2009
Imidazo-pyrazine derivatives as potent CXCR3 antagonists
Xiaohui Du, Darin J Gustin, Xiaoqi Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 26, 2009
Identification of a PPARdelta agonist with partial agonistic activity on PPARgamma
Richard V Connors, Zhulun Wang, Martin Harrison, et al.
Bioorganic & Medicinal Chemistry
|
September 16, 2008
Distinctive molecular inhibition mechanisms for selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1
Hua Tu, Jay P Powers, Jinsong Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 20, 2014
Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4
Yingcai Wang, Richard Connors, Pingchen Fan, et al.
Journal of Molecular Biology
|
May 20, 2009
INT131: a selective modulator of PPAR gamma
Alykhan Motani, Zhulun Wang, Jennifer Weiszmann, et al.
Journal of Medicinal Chemistry
|
March 31, 2012
Structure-guided design, synthesis, and evaluation of guanine-derived inhibitors of the eIF4E mRNA-cap interaction
Xiaoqi Chen, David J Kopecky, Jeff Mihalic, et al.
The Journal of Biological Chemistry
|
May 26, 2018
Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2
Athena Sudom, Santosh Talreja, Jean Danao, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2009
Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)
Daqing Sun, Zhulun Wang, Mario Cardozo, et al.
Page
of 7